23 Jan Carisma Therapeutics
Tom Wilton, Chief Business Officer
April 13 | 10:45am | Dark Horse Consulting Ballroom
Carisma Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors.